Meningococcal Groups C and Y/Haemophilus b Conjugate Vaccine: References

Meningococcal/Haemophilus b vaccine. 2016 Clinical Pharmacology. Accessed 10/26/16 from http://clinicalpharmacology.com

Advisory Committee on Immunization Practices (ACIP) and Centers for Disease Control and Prevention (CDC). Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2013. Accessed 10/26/16 from http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6202a1.htm

Advisory Committee on Immunization Practices (ACIP) and Centers for Disease Control and Prevention (CDC). Prevention and Control of Haemophilus influenzae Type b Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Accessed 10/24/16 from http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6301a1.htm.

Advisory Committee on Immunization Practices (ACIP) and Centers for Disease Control and Prevention (CDC). Use of MenACWY-CRM Vaccine in Children Aged 2 Through 23 Months at Increased Risk for Meningococcal Disease: Recommendations of ACIP, 2013. Accessed 10/24/16 from http://www.cdc.gov/mmwr/pdf/wk/mm6324.pdf

Menhibrix (meningococcal groups c and y and haemophilus b tetanus toxoid conjugate vaccine). 2013 GSK. Accessed 10/26/16 from https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=be1e867a-51d2-4e07-bea3-6096221eec48.